Pharmaceutical strategy

This page is also available in

Dictamen de la Sección del CESE: Pharmaceutical strategy

The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.

Practical information

  1. Composition of the study group
  2. Administrator in charge / Assistant: Dalila BERNARD / Tanja STANOVNIK
  3. For more information please contact the INT Section Secretariat.